Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Rofecoxib

A non-steroidal anti-inflammatory drug that selectively inhibits COX-2 (a coxib), on the market from 1999 to 2004 for osteoarthritis, rheumatoid arthritis, acute pain, migraine and dysmenorrhoea. This family brings together the active ingredient and labelled standards.

Did you know?Its target, the COX-2 enzyme, had only been confirmed and cloned in 1991: in eight years the path led from the discovery of the enzyme to a marketed medicine.

RofecoxibGo to the active ingredient →
RofecoxibActive ingredientRofecoxibCat. No. P-R079-001CAS 162011-90-7
Rofecoxib-d5Isotopically labelledRofecoxib-d5Cat. No. P-R079-002CAS 544684-93-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.